期刊文献+

氯沙坦钾和非洛地平治疗老年高血压合并高尿酸血症的疗效 被引量:1

下载PDF
导出
摘要 目的 观察比较氯沙坦钾和非洛地平治疗老年高血压合并高尿酸血症的临床效果.方法 选取2010 年6 月~ 2012 年6 月收治的老年高血压患者合并高尿酸血症对象共68 例,随机分为两组,每组34 例,对照组给予非洛地平缓释片,每日1 次,每次5 mg,连用6 周; 治疗组给予氯沙坦钾,每日1 次,每次50 mg,连用6 周.观察两组的血压和血尿酸变化.结果 氯沙坦钾组和非洛地平组均有良好的降压效果,差异无统计学意义(P 〉 0.05).氯沙坦钾组治疗后血尿酸水平与治疗前相比显著降低(P 〈 0.05);非洛地平组治疗前后血尿酸水平无明显变化.结论 对于老年性高血压合并高尿酸血症者,氯沙坦钾有良好的降压和降尿酸作用.
作者 宋宏界
出处 《中国处方药》 2014年第11期39-40,共2页 Journal of China Prescription Drug
  • 相关文献

参考文献6

  • 1Abbott RD, Brand FN, Kannel WB, et al. Goutand coronarydisease: the framingham study. J Clin Epidemiol, 1988, 41(3):237-242.
  • 2高庆林.血尿酸测定在高血压疾病中的临床应用[J].中国现代医生,2008,46(15):211-211. 被引量:4
  • 3Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk.N Engl J Med, 2008, 359(17):1811-1821.
  • 4Bos MJ, Koudstaal PJ, Hofman A, et al. Uric acid is a risk factorfor myocardial infarction and stroke:the RotterdamStudy. Stroke, 2006, 37(6):1503-1507.
  • 5Edwards RM, Trizna W, Stack EJ, et al. Interaction of nonpeptideangiotension receptor antagonists with the urate Ⅱ transporter in rat renalbrush border membranes. J Pharmacol Exp Ther, 1996, 276(1):125-129.
  • 6党爱民,刘国仗,张宇辉,陈改玲.血管紧张素Ⅱ受体拮抗剂干预高血压患者尿酸代谢的对比研究[J].中华心血管病杂志,2006,34(10):882-885. 被引量:59

二级参考文献21

  • 1[2]Johnson RJ,Kang D,Feig DI.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal diease[J].Hypertension,2003,41(6):1183-1190.
  • 2Moriarity JT,Folsom AR,Iribarren C,et al.Serum uric acid and risk of coronary heart disease:Atherosclerosis Risk in Communities(ARIC) Study.Ann Epidemiol,2000,10:136-143.
  • 3Breckenridge A.Hypertension and hyperuricaemia.Lancet,1966,1:15-18.
  • 4Cannon PJ,Stason WB,demartini FE,et al.Hyperurcemia in primary and renal hypertension.N Engl J Med,1966,275:457-464
  • 5Johnson RJ,Kang DH,Feig D,et al.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease.?Hypertension,2003,41:1183-1190.
  • 6Hoieggen A,Alderman MH,Kjeldsen SE,et al.The impact of serum uric acid on cardiovascular outcomes in the LIFE study.Kidney Int,2004,65:1041-1049.
  • 7孟昭亨.尿酸与痛风.见:方圻,主编.现代内科学.北京:人民军医出版社,1995.2868-2878.
  • 8Nakashima M,Uematsu T,Kosuge K,et al.Pilot study of the uricosuric effect of DuP-753,a new angiotensin Ⅱ receptor antagonist,in healthy subjects.Eur J Clin Pharmacol,1992,42:333-335.
  • 9Sweet CS,Bradstreet DC,Berman RS,et al.Pharmacodynamic activity of intravenous E-3174,an angiotensin Ⅱ antagonist,in patients with essential hypertension.Am J Hypertens,1994,7:1035 -1040.
  • 10Wurzner G,Gester JC,Chiolero A,et al.Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout.J Hypertens,2001,19:1855-1860.

共引文献61

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部